Sreeja Sanampudi

Markey Cancer Center

Papers

1

Total Citations

40

H-Index

1

About

Sreeja Sanampudi is a prominent researcher in head and neck oncology, with a particular focus on optimizing treatment strategies for oropharynx cancer. Her most cited work, a 2019 study comparing outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery (TORS) versus definitive chemoradiation, has garnered 40 citations and represents a critical contribution to the ongoing debate between surgical and non-surgical approaches. This research directly addresses the challenge of balancing oncologic efficacy with functional preservation, providing valuable data that helps guide clinical decision-making for patients and clinicians. Sanampudi’s work underscores the importance of personalized treatment pathways in an era of evolving therapeutic options. By rigorously analyzing real-world outcomes, she has helped clarify the role of TORS as a viable alternative to chemoradiation, particularly for select patient populations. Her scholarship is essential reading for anyone interested in the intersection of surgical innovation and radiation oncology, and it continues to influence practice patterns in head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation
40 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Markey Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago